In prostate cancer (PC), prostate-specific antigen (PSA) serum level is not significantly different in patients with CTC-negative and positive samples, suggesting that the major source of PSA serum is not related to PSA—Secreting CTCs but rather to the tumor itself, independently from its transformation condition [34]. This evidence concerns the gene KLK3 and neoplasm.